Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 100 participants.
Also called NCT06782646
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06782646
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Hong Kong SAR China
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT06782646. Randomized; double masking; primary purpose prevention. Start 2024-08-01 (actual); primary completion 2025-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Berberine
- Intervention (Drug)
- Placebo
- Lead sponsor
- The University of Hong Kong
Record details
- Record id
cardio:ct-nct06782646- Content hash
14febb0ed14c22a4dc4084e06d0e450079039f35d6dcc015eb136887ebdec34b